This inventor holds 6 USPTO granted patents and 5 published patent applications, plus 7 CIPO patents and 5 EPO patents. Top assignee: Institute of Organic Chemistry and Biochemistry. Active years: 2021-2025.
Company Filing History:
Years Active: 2021-2025
Title: Ondrej Pav: Innovator in Cyclic Dinucleotide Research
Introduction
Ondrej Pav is a prominent inventor based in Prague, Czech Republic. He has made significant contributions to the field of organic chemistry, particularly in the development of cyclic dinucleotides and their applications in medicine. With a total of six patents to his name, Pav is recognized for his innovative approaches to treating diseases through STING protein modulation.
Latest Patents
Among his latest patents, Ondrej Pav has developed a compound titled "2'3′-cyclic dinucleotides and prodrugs thereof." This patent focuses on 2'3′ cyclic phosphonate dinucleotides, which include pharmaceutically acceptable salts and compositions aimed at treating or preventing diseases modifiable by STING protein modulation, such as cancer and various viral, allergic, and inflammatory diseases. Another notable patent is the "3'3′-cyclic dinucleotide analogue comprising a cyclopentanyl modified nucleotide as STING modulator." This invention relates to 3'3′-cyclic dinucleotides that can modulate the activity of the STING adaptor protein, showcasing Pav's commitment to advancing therapeutic options.
Career Highlights
Ondrej Pav is affiliated with the Institute of Organic Chemistry and Biochemistry, ASCR, v.v.i., where he conducts his research. His work has garnered attention in the scientific community, particularly for its potential impact on drug development and disease treatment. His innovative research has positioned him as a key figure in the field of organic chemistry.
Collaborations
Pav collaborates with esteemed colleagues such as Gabriel Birkus and Ivan Rosenberg. These partnerships enhance the research environment and contribute to the advancement of their collective work in the field.
Conclusion
Ondrej Pav's contributions to cyclic dinucleotide research exemplify the intersection of innovation and medicine. His patents reflect a dedication to improving therapeutic strategies for complex diseases. Through his work, he continues to influence the landscape of organic chemistry and its applications in healthcare.